Related Experiment Video
Updated: Aug 11, 2026
14:04
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Oxacillin-resistant and multidrug-resistant Staphylococcus aureus in Lima, Peru
1Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, AP 4314, Lima 100, Peru. cseas@upch.edu.pe
Infection Control and Hospital Epidemiology
|February 9, 2006
Summary
A 2002 study in Lima, Peru, found 68% of Staphylococcus aureus infections were resistant to oxacillin. Prior antibiotic use and surgery increased the risk of these drug-resistant S. aureus strains.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Hospital Epidemiology
Background:
- Staphylococcus aureus is a common cause of hospital-acquired infections.
- Antimicrobial resistance, particularly oxacillin resistance, is a growing global health concern.
- Understanding risk factors for oxacillin-resistant S. aureus (ORSA) is crucial for infection control.
Purpose of the Study:
- To determine the prevalence of oxacillin-resistant S. aureus (ORSA) in a Peruvian hospital.
- To identify risk factors associated with ORSA infections in hospitalized patients.
Main Methods:
- Retrospective review of 103 Staphylococcus aureus infection cases.
- Data collected in a Lima, Peru hospital during 2002.
- Analysis of antibiotic resistance patterns and patient clinical data.
Main Results:
- The prevalence of oxacillin-resistant S. aureus (ORSA) was 68%.
- 25% of S. aureus strains exhibited multidrug resistance.
- Previous antibiotic exposure and recent surgical procedures were significantly associated with ORSA.
Conclusions:
- Oxacillin-resistant S. aureus (ORSA) represents a substantial burden in this Peruvian hospital setting.
- Antibiotic stewardship and infection prevention strategies targeting surgical patients are warranted.
- Further research into local resistance mechanisms and epidemiology is recommended.
Related Concept Videos
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
00:57Antibiotic Selection
Overview